Cortes, JE; Esteve, J; Bajel, A; Yee, K; Braun, T; De Botton, S; Peterlin, P; Recher, C; Thomas, X; Watts, J; Sangerman, MA; Curti, A; Grove, C; Jonas, BA; Lanza, F; Legrand, O; Montesinos, P; Patel, P; Prebet, T; Wang, ES; Polyanskaya, O; Brevard, J; Sweeney, J; Fenaux, P; Wei, AH, Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia, «BLOOD», 2021, 138, pp. 698 - 698 [Abstract]
Fontana, Maria Chiara; Nanni, Jacopo; Ghelli Luserna di Rorà, Andrea; Petracci, Elisabetta; Padella, Antonella; Ghetti, Martina; Ferrari, Anna; Marconi, Giovanni; Soverini, Simona; Iacobucci, Ilaria; Papayannidis, Cristina; Curti, Antonio; Audisio, Ernesta; Giannini, Maria Benedetta; Rondoni, Michela; Lanza, Francesco; Cavo, Michele; Martinelli, Giovanni; Simonetti, Giorgia, Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a, «BIOMEDICINES», 2021, 9, pp. 1 - 19 [Scientific article]
Fontana M.C.; Nanni J.; Di Rora A.G.L.; Petracci E.; Padella A.; Ghetti M.; Ferrari A.; Marconi G.; Soverini S.; Iacobucci I.; Papayannidis C.; Curti A.; Audisio E.; Giannini M.B.; Rondoni M.; Lanza F.; Cavo M.; Martinelli G.; Simonetti G., Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a, «BIOMEDICINES», 2021, 9, pp. 388 - 388 [Scientific article]Open Access
Francesco Lanza, PNH CLONES PREVALENCE STUDY IN PH-NEGATIVE MYELOPROLIFERATIVE DISORDERS, «HAEMATOLOGICA», 2021, 110, pp. 85 - 86 [Abstract]
Venditti, A; Piciocchi, A; Palmieri, R; Arena, V; Candoni, A; Calafiore, V; Melillo, LM; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, MI; Paterno, G; Buzzatti, E; Voso, MT; Ottone, T; Consalvo, MI; Fazi, P; Vignetti, M; Arcese, W; Amadori, S; Buccisano, F, Results of the 6-Year Follow- up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia, «BLOOD», 2021, 138, pp. 2359 - 2359 [Abstract]
Lanza, Francesco; Bazarbachi, Ali, Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions, «CANCERS», 2021, 13, pp. 4698 - 4698 [Abstract]
Lanza, Francesco; Bazarbachi, Ali, Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions, «CANCERS», 2021, 13, Article number: 4698 , pp. 1 - 5 [Scientific article]Open Access
Gottardi, Michele; Simonetti, Giorgia; Sperotto, Alessandra; Nappi, Davide; Ghelli Luserna di Rorà, Andrea; Padella, Antonella; Norata, Marianna; Giannini, Maria Benedetta; Musuraca, Gerardo; Lanza, Francesco; Cerchione, Claudio; Martinelli, Giovanni, Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin, «CANCERS», 2021, 13, pp. 4566 - 4566 [Scientific article]Open Access
Lanza, Francesco; Agostini, Vanessa; Monaco, Federica; Passamonti, Francesco; Seghatchian, Jerard, Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders, «CLINICAL HEMATOLOGY INTERNATIONAL», 2021, 3, pp. 77 - 82 [Scientific article]
Gambacorti-Passerini, Carlo; Ruggeri, Marco; Aroldi, Andrea; Piazza, Rocco; Mazzi, Angela; De Silvestro, Giustina; Krampera, Mauro; Lanza, Francesco, Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies, «TRANSFUSION AND APHERESIS SCIENCE», 2021, 60, pp. 103105-1 - 103105-2 [Scientific article]
Francesco Lanza, 5 Anni di Ematologia a Ravenna e in Romagna, Ravenna, Legatoria Universo, 2021, pp. 26 . [Research monograph]
Lanza F; Seghatchian j, An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy, «TRANSFUSION AND APHERESIS SCIENCE», 2020, 59, Article number: 102940 , pp. 1 - 3 [Scientific article]
Lanza F.; Maffini E.; Rondoni M.; Massari E.; Faini A. C.; Malavasi F., CD22 expression in b-cell acute lymphoblastic leukemia: Biological significance and implications for inotuzumab therapy in adults, «CANCERS», 2020, 12, Article number: 303 , pp. 1 - 15 [Scientific article]Open Access
Maffini, Enrico; Labopin, Myriam; Blaise, Didier; Ciceri, Fabio; Gülbas, Zafer; Deconinck, Eric; Leblond, Veronique; Chevallier, Patrick; Sociè, Gerard; Araujo, Mercedes Colorado; Koc, Yener; Savani, Bipin N; Gorin, Norbert Claude; Lanza, Francesco; Nagler, Arnon; Mohty, Mohamad, CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), «AMERICAN JOURNAL OF HEMATOLOGY», 2020, 95, pp. 892 - 899 [Scientific article]Open Access
Roberta Rizzo; Diana Campioni; Daria Bortolotti; Francesco Lanza, Clinical applications of mesenchymal stromal cells in stem cell transplantation, in: Gian Paolo Bagnara, Stem Cells, BOLOGNA, Esculapio, 2020, pp. 261 - 268 [Chapter or essay]
